Live Breaking News & Updates on Cephea Valve Technologies Inc

Stay updated with breaking news from Cephea valve technologies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021


Share this article
Share this article
ABBOTT PARK, Ill., Jan. 27, 2021 /PRNewswire/  Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2020, and issued its financial outlook for 2021.
Fourth-quarter sales of $10.7 billion increased 28.7 percent on a reported basis and 28.4 percent on an organic basis, which excludes the impact of foreign exchange.
Fourth-quarter GAAP diluted EPS was $1.20 and adjusted diluted EPS, which excludes specified items, was $1.45, reflecting 52.6 percent growth versus the prior year.
1
Full-year 2020 GAAP diluted EPS from continuing operations was $2.49 and adjusted diluted EPS from continuing operations was $3.65, at the upper-end of guidance range issued in January 2020. ....

Markp Christiansen , Kristin Castorino , Hanqing Liu , Gregory Forlenza , Ronald Brazg , Mark Kipnes , Robertb Ford , Abbott Binax , Davidr Liljenquist , Erwins Budiman , Timothy Bailey , Alva Shridhara , World Health Organization , Abbott Laboratories , Cephea Valve Technologies Inc , Core Laboratory , Freestyle Libre , Libre Sense Glucose Sport Biosensor , Adult Nutrition , Pediatric Nutrition , Use Authorization , Emerging Markets , Product Lines , Medical Devices , Diabetes Care , Aristocrats Index ,